Food and Drug Regulations, C.R.C., c. 870

Section C.01.032

Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.01.032 · current to June 17, 2026 · regulation last amended June 17, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

No person shall sell a corticosteroid drug for ophthalmic use unless (a) the outer label or the package insert carries, as part of the directions for use, the following statements:“ContraindicationsViral diseases of the cornea and conjunctiva;Tuberculosis of the eye;Fungal diseases of the eye;Acute purulent untreated infections of the eye, which, like other diseases caused by micro-organisms, may be masked or enhanced by the presence of the steroid.Side EffectsExtended ophthalmic use of corticosteroid drugs may cause increased intraocular pressure in certain individuals and in those diseases causing thinning of the cornea, perforation has been known to occur.”;and (b) the inner label carries the statements required by paragraph (a) or instructions to see the outer label or package insert for information about contraindications and side effects.
Read the Food and Drug Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.